The KCTD15 Knockout SK-HEP-1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human hepatic adenocarcinoma SK-HEP-1 cell line, engineered for targeted disruption of the KCTD15 gene. This loss-of-function model enables investigation of KCTD15-dependent processes, including its role as a substrate adaptor for the CUL3-RBX1 E3 ubiquitin ligase complex. The polyclonal nature of the knockout population reflects a heterogeneous mix of edited alleles, providing a robust tool for studying gene function without the clonal biases inherent to single-cell-derived lines.
The host cell line, SK-HEP-1, is a well-characterized human hepatic adenocarcinoma model originally isolated from the ascitic fluid of a patient with liver carcinoma. Notably, SK-HEP-1 cells exhibit endothelial-like properties, expressing markers such as CD34 and von Willebrand factor, and are widely employed in studies of liver cancer biology, endothelial differentiation, and tumor microenvironment interactions. This unique dual phenotype situates SK-HEP-1 as a versatile platform for examining the intersection of hepatic malignancy and endothelial-like signaling pathways.
KCTD15 operates as a substrate-specific adapter for the CUL3-RBX1 E3 ubiquitin ligase complex, directing the ubiquitination and proteasomal degradation of key regulatory proteins. Primary targets include ??-catenin (CTNNB1), the central transducer of Wnt/??-catenin signaling, and the transcription factor TFAP2A, which orchestrates neural crest development. By targeting ??-catenin for destruction, KCTD15 negatively regulates Wnt signaling downstream of Wnt ligands, Frizzled receptors, Dishevelled (DVL), and the GSK-3?? destruction complex, thereby attenuating TCF/LEF-mediated gene expression. KCTD15 also interacts with HDAC1 and the LIM-domain protein FHL2, and its activity is subject to regulation by BMP signaling through SMAD1/5/8 and by TFAP2A itself, forming a reciprocal regulatory circuit that integrates Wnt, BMP, and neural crest specification programs.
In the SK-HEP-1 hepatic adenocarcinoma background, KCTD15 knockout provides a pertinent model to dissect the contribution of ubiquitin-mediated protein turnover to liver cancer cell biology. This polyclonal knockout population enables functional studies on how loss of KCTD15 affects Wnt pathway activity, potentially resulting in stabilized ??-catenin and enhanced oncogenic signaling, as well as altered TFAP2A stability influencing proliferation, migration, and endothelial-like characteristics. By eliminating KCTD15 in a cell line with hepatic and endothelial features, researchers can interrogate the gene’s role in tumor growth dynamics and the acquisition of endothelial-like properties often associated with aggressive cancer phenotypes.
Applications include analysis of KCTD15-mediated ubiquitination via co-immunoprecipitation and ubiquitination assays, measurement of ??-catenin levels by Western blotting and RT-qPCR, and functional assessment using ??-catenin reporter assays, proliferation and migration assays, and cell cycle analysis. The polyclonal knockout population is well-suited for investigating Wnt/BMP crosstalk and screening modulators in a heterogeneous background. For inquiries, contact Ascent Research.
